Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Long-acting Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning
    Release Date:
    Partner:

    Lilly

    Review Process: Pfizer Internal
    Education Internal Medicine All
    NASH – Future of Non-invasive Diagnosis Technologies
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)
    Release Date:
    Partner:

    International Society for Infectious Diseases (ISID)

    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Advances in Oncology Therapy in Renal Cell Carcinoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region
    Release Date:
    Partner:

    RCNi (subsidiary of the Royal College of Nursing)

    Review Process: Pfizer Internal
    Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Argentina, Brazil, Chile, Colombia
    Vaccine Preventable Diseases – COVID-19 (closed early)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All